I agree dino, reminds me of the argument between Jonny and blackdiamonds who were both right.
Many companies are valued on potential especially those in the biotech sector.
However IMO before GFC, it was not uncommon that companies were valued on huge PE multiples. But now, if you're not earning revenues, the market is going to downgrade you which is happening to UNS.
